fda import alert semaglutide green list glp-1 tirzepatide 2025 SFDA updates guidelines for pharmaceutical variation requirements FDA Import Alert 66-80: GLP-1 – FDA's green list cracks down

Inflammatory versus neoplastic, mucinous versus non-mucinous, and duct communication remain the core branch points before surveillance or EUS-FNA is planned

Squalene was not detectable in oocysts, but cholesterol was

That leeway will continue until April 22 for many pharmacies and May 22 for outsourcing facilities to "avoid unnecessary disruption" to patients, the agency said

The liposomal formulation reduces kidney toxicity while improving targeted drug delivery

Cel Biol 16 (11), 10351044

Joseph Zucchi, PA-C, MPAS, is a board-certified physician associate specializing in obesity medicine and clinical supervisor at Transition Medical Weight Loss in Salem, New Hampshire